 | Up a level |
Anderson, C; Antonello, M; Baller, B; Bolton, T; Bromberg, C; Cavanna, F; Church, E; Edmunds, D; Ereditato, A; Farooq, S; Fleming, B; Greenlee, H; Guenette, R; Haug, S; Horton-Smith, G; James, C; Klein, E; Lang, K; Lathrop, A; Laurens, P; ... (2012). The ArgoNeuT detector in the NuMI low-energy beam line at Fermilab. Journal of instrumentation, 7(10), P10019-P10019. London: Institute of Physics Publishing IOP 10.1088/1748-0221/7/10/P10019
Rieder, H L; Anderson, C; Dara, M; Hauer, B; Helbling, P; Kam, K M; Zwahlen, M (2011). Methodological issues in quantifying the magnitude of the tuberculosis problem in a prison population. International journal of tuberculosis and lung disease, 15(5), pp. 662-667. Paris: International Union Against Tuberculosis and Lung Disease IUATLD 10.5588/ijtld.10.0433
Buse, JB; Rosenstock, J; Sesti, G; Schmidt, WE; Montanya, E; Brett, JH; Zychma, M; Blonde, L; Ahmed, A; Alvarsson, M; Anderson, C; Aoki, A; Aranko, S; Bailey, B; Barbonta, D; Baur, C; Bednarczyk-Kaluzny, M; Blevins, T; Blonde, L; Bode, B; ... (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet, 374(9683), pp. 39-47. London: Elsevier 10.1016/S0140-6736(09)60659-0
